Innovating with Quality and Expertise.
In 2018, Medentech officially joined the Kersia group. This strategic move aimed to strengthen and expand Kersia’s position in the medical and water treatment sectors, leveraging Medentech, now Kersia Healthcare’s extensive expertise and established market presence in these critical areas.
Medentech was founded in 1984 and, due to significant growth, opened a state-of-the-art production facility in Wexford in 1997. Our manufacturing journey began with Sterinova, a baby bottle sterilising product. Shortly after, we introduced Aquatabs water purification tablets, designed for emergency use in developing countries. Medentech also developed a range of surface cleaning and disinfection products to meet the demand for hospital disinfectants, eventually exporting to over 120 countries.
We believe safe drinking water should be accessible to all. From urban cities to small villages, the future starts with water. Our vision is a world where everyone can access drinking water and fulfil their true potential. We work to overcome waterborne illness through forward-thinking solutions and global collaborations and strengthen individuals and communities.
To deliver universal access to drinking water and unlock human potential worldwide. Our mission is to deliver universal access to drinking water and better health for all. We develop reliable solutions to overcome waterborne illness and unlock human potential worldwide.
Aquatabs was founded with a mission to provide safe drinking water to communities in need.
Aquatabs reached a milestone of providing clean water to 1 million people.
Aquatabs expanded its operations to reach communities in remote areas.
Aquatabs received recognition for its innovative water purification technology.
Aquatabs received recognition for its innovative water purification technology.
Aquatabs received recognition for its innovative water purification technology.
Medentech was founded with Sterinova, a fast-acting, effective effervescent tablet for disinfecting infant feeding bottles on the go
Aquasept and Klorsept developed and launched.
Aquatabs brand established and distributed for emergency situations worldwide.
Klorkleen effervescent disinfection and cleaning tablets designed for hospital infection prevention were launched.
A new state-of-the-art production facility is opened on Clonard Road.
Aquatabs approved by WHO for continuous use.
US Klorkleen developed and received EPA approval
Aquatabs launched as HWTS solution
Development of a Flogenic chlorinator, an in-tank water disinfection unit.
Medentech was acquired by Anti-Germ
Aquatabs Flo, a new water disinfection system solution from Aquatabs, becomes the basis of a double-blind cluster-randomised controlled water treatment intervention trial in Bangladesh.
Paragon Partners acquire Anti-Germ and Medentech
Fortune Magazine named Medentech one of the “Companies that are changing the world.”
Every Woman, Every Child Commitment
Medentech is dedicated to helping achieve SDGs by improving access to safer water and reducing surface contamination. In support of Every Woman, Every Child, Medentech committed to increasing the volume of water treated from 11 billion in 2016 to 15 billion by 2020
We are now Kersia! Hypred, Anti-Germ, Medentech, LCB Food Safety and G3 have adopted a unique name – Kersia. The group continues to grow, expanding into Canada and North America.
NaDCC Klorkleen 2 – US EPA registers KK2 (EPA 71847-7) as the first product to be effective against biofilms. The EPA developed a new efficacy protocol, KK2 effervescent disinfection tablets 1st, to pass this test.
A peer-reviewed article titled “Effect of in-line drinking water chlorination at the point of collection on child diarrhoea in urban Bangladesh: a double-blind, cluster-randomised controlled trial” was published in the world-famous Lancet medical journal. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30315-8/fulltext
Commitment to WASH in Healthcare facilities
In the second half of 2019, Aquatabs and Impact Water rolled out infection prevention solutions to Kenyan healthcare facilities, dispensaries, and hospitals to support the Global Health Council initiative to achieve universal WASH coverage in healthcare facilities by 2030.
The peer-reviewed article “The Impact of a Continuously Active Disinfectant on Bacterial Surface Concentrations and Biofilm Growth” has just been published in the US, and the results show our NaDCC disinfectant tablet with detergent, Klorkleen2 effectively limits transmission of Staphylococcus aureus and Clostridioides difficile. https://www.infectioncontroltoday.com/view/continuous-acting-disinfectant-appears-to-work-better-on-surfaces
Major article “Effects of a Water, Sanitation, and Hygiene Mobile Health Program on Diarrhoea and Child Growth in Bangladesh: A Cluster-randomized Controlled Trial of the Cholera Hospital-based Intervention for 7 Days (CHoBI7) Mobile Health Program” published. Findings: The CHoBI7 mHealth program using Aquatabs water disinfection tablets lowered paediatric diarrhoea and stunting among diarrhoea patient households.
From 7 billion litres in 2015 to Aquatabs disinfect 40 billion litres of water globally in 2022
Alban Houssin was appointed vice president of the Healthcare and water sector. Alban’s appointment aligns perfectly with our vision, and we are confident that his insights and strategic approach will drive us forward.
Move to a career that saves lives and empowers communities through innovative water purification solutions.
Get in touch᛫Get in touch᛫Get in touch᛫Get in touch᛫Get in touch᛫Get in touch᛫
Your support extends clean water access. Join us today to be part of the solution!
